These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9750021)

  • 21. Telomerase activity and human telomerase reverse transcriptase expression in colorectal carcinoma.
    Liu JL; Ge LY; Zhang GN
    World J Gastroenterol; 2006 Jan; 12(3):465-7. PubMed ID: 16489651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Missing association between telomerase activity and clinicopathological features in patients with early stage carcinoma of the cervix.
    Santos-Filho AS; Triginelli SA; Traiman P; Cunha-Melo JR; Silva-Filho AL
    Arch Gynecol Obstet; 2007 Jan; 275(1):13-7. PubMed ID: 16858573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between telomerase, p53, and clinical staging in colorectal cancer.
    Brown T; Aldous W; Lance R; Blaser J; Baker T; Williard W
    Am J Surg; 1998 May; 175(5):364-6. PubMed ID: 9600278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase activity in esophageal carcinoma.
    Takubo K; Nakamura K; Izumiyama N; Mafune K; Tanaka Y; Miyashita M; Sasajima K; Kato M; Oshimura M
    J Surg Oncol; 1997 Oct; 66(2):88-92. PubMed ID: 9354162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Change in telomerase activity during human colorectal carcinogenesis.
    Yoshida R; Kiyozuka Y; Ichiyoshi H; Senzaki H; Takada H; Hioki K; Tsubura A
    Anticancer Res; 1999; 19(3B):2167-72. PubMed ID: 10472326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase activity in periampullary tumors correlates with aggressive malignancy.
    Balcom JH; Keck T; Warshaw AL; Antoniu B; Graeme-Cook F; Fernández-del Castillo C
    Ann Surg; 2001 Sep; 234(3):344-50; discussion 350-1. PubMed ID: 11524587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Telomerase activity in colorectal cancer--a semi-quantitative procedure].
    Ohki S; Satoh H; Watanabe F; Andoh Y; Nomizu T; Yoshida T; Tsuchiya A; Abe R; Yamaki Y
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():469-74. PubMed ID: 9589055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase activity in colorectal cancer and its relationship to bcl-2 expression.
    Iida A; Yamaguchi A; Hirose K
    J Surg Oncol; 2000 Apr; 73(4):219-23. PubMed ID: 10797335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
    Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; Takahashi S; Negoro K; Shimosegawa T; Toyota T
    Cancer; 1999 Oct; 86(8):1431-6. PubMed ID: 10526269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-methylacyl-CoA racemase/P504S overexpression in colorectal carcinoma is correlated with tumor differentiation.
    Shi X; Gong E; Wu X
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):175-80. PubMed ID: 17525630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of telomerase activity and telomere length in the preoperative diagnosis of gastric and colorectal cancer.
    Katayama S; Shiota G; Oshimura M; Kawasaki H
    J Cancer Res Clin Oncol; 1999 Jul; 125(7):405-10. PubMed ID: 10394961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased telomerase activities in human pancreatic duct adenocarcinomas.
    Tsutsumi M; Tsujiuchi T; Ishikawa O; Majima T; Yoshimoto M; Sasaki Y; Fukuda T; Oohigashi H; Konishi Y
    Jpn J Cancer Res; 1997 Oct; 88(10):971-6. PubMed ID: 9414659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
    Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
    Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P21WAF1/CIP1 expression in colorectal carcinomas is related to Kras mutations and prognosis.
    Mitomi H; Ohkura Y; Fukui N; Kanazawa H; Kishimoto I; Nakamura T; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Saigenji K
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):883-9. PubMed ID: 17873613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
    Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved prognosis of solid-type poorly differentiated colorectal adenocarcinoma: a clinicopathological and immunohistochemical study.
    Sugao Y; Yao T; Kubo C; Tsuneyoshi M
    Histopathology; 1997 Aug; 31(2):123-33. PubMed ID: 9279562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
    Martín R; Nieto S; Santamaría L
    Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.
    Zheng HC; Zheng YS; Xia P; Xu XY; Xing YN; Takahashi H; Guan YF; Takano Y
    Histol Histopathol; 2010 Apr; 25(4):445-52. PubMed ID: 20183797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma.
    Engin A; Gonul II; Engin AB; Karamercan A; Sepici Dincel A; Dursun A
    World J Gastroenterol; 2016 Apr; 22(13):3592-601. PubMed ID: 27053851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.